Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Ross

Showing results (41-50 of 130) with videos related to

Pageof 13
Sort By:
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Pathology|December 9, 2023
Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryWei Yang Ng, Wendy N Erber, Andrew Grigg, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Internal Medicine Journal|February 2, 2018
Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factorsDavid M Ross, Chris Arthur, Kate Burbury, et al.
Blood Cancer Discovery|July 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery ApproachesPramod C Nair, Jacob Piehler, Denis Tvorogov, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
American Journal of Hematology|July 8, 2022
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosisJacinta Perram, David M Ross, Donal McLornan, et al.
British Journal of Haematology|June 25, 2015
Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long-term treatment with subcutaneous protein C concentrateJir P Boey, Alexandra Jolley, Catherine Nicholls, et al.
Internal Medicine Journal|March 6, 2017
A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisP Joy Ho, Ashish Bajel, Kate Burbury, et al.
Leukemia & Lymphoma|June 16, 2017
Patient perceptions of treatment-free remission in chronic myeloid leukemiaLucia A Villemagne Sanchez, Clare O'Callaghan, Karla Gough, et al.
Pageof 13

Showing results (41-50 of 130) with videos related to

Sort By:
Pageof 13
British Journal of Haematology|January 14, 2010
Rapid isolation of translocation breakpoints in chronic myeloid and acute promyelocytic leukaemiaPaul A Bartley, Michael H Martin-Harris, Bradley J Budgen, et al.
Pathology|December 9, 2023
Variability of bone marrow biopsy reporting affects accuracy of diagnosis of myeloproliferative neoplasms: data from the ALLG MPN01 registryWei Yang Ng, Wendy N Erber, Andrew Grigg, et al.
Haematologica|August 11, 2011
Durable complete molecular remission of chronic myeloid leukemia following dasatinib cessation, despite adverse disease featuresDavid M Ross, Paul A Bartley, Jarrad Goyne, et al.
Internal Medicine Journal|February 2, 2018
Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factorsDavid M Ross, Chris Arthur, Kate Burbury, et al.
Blood Cancer Discovery|July 27, 2023
Next-Generation JAK2 Inhibitors for the Treatment of Myeloproliferative Neoplasms: Lessons from Structure-Based Drug Discovery ApproachesPramod C Nair, Jacob Piehler, Denis Tvorogov, et al.
Pharmaceutics|February 24, 2024
Combating Acute Myeloid Leukemia via Sphingosine Kinase 1 Inhibitor-Nanomedicine Combination Therapy with Cytarabine or VenetoclaxThao M Nguyen, Paul Joyce, David M Ross, et al.
American Journal of Hematology|July 8, 2022
Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosisJacinta Perram, David M Ross, Donal McLornan, et al.
British Journal of Haematology|June 25, 2015
Novel protein C gene mutation in a compound heterozygote resulting in catastrophic thrombosis in early adulthood: diagnosis and long-term treatment with subcutaneous protein C concentrateJir P Boey, Alexandra Jolley, Catherine Nicholls, et al.
Internal Medicine Journal|March 6, 2017
A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisP Joy Ho, Ashish Bajel, Kate Burbury, et al.
Leukemia & Lymphoma|June 16, 2017
Patient perceptions of treatment-free remission in chronic myeloid leukemiaLucia A Villemagne Sanchez, Clare O'Callaghan, Karla Gough, et al.
Pageof 13